Comparison of wireless handheld ultrasound and high-end ultrasound in pediatric patients with venous malformations – First results

Barbara Greiner(University Hospital Regensburg), Ernst Michael Jung(University Hospital Regensburg), Christian Stroszczynski(University Hospital Carl Gustav Carus), Natascha Platz Batista da Silva(RoMed Kliniken), Simone Hammer(University Hospital Regensburg), Ulrich Kaiser(University of Applied Sciences Landshut)

Clinical Hemorheology and Microcirculation

August 25, 2023

10.3233/ch-238106

Cited by 1

Related Papers

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

|The Lancet|2013|1.5k

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

|The Lancet Oncology|2009|960

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

|The Lancet Oncology|2015|402

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

|Annals of Oncology|2006|280

<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

|Blood|2021|170